<i>HLA‐DRB5*01:133</i>, the First <scp>HLA</scp>‐<scp>DRB5</scp> Allele With Arginine at Position 16 in the Peptide‐Binding Domain

A transition in codon 16 in the peptide-binding domain results in the novel HLA-DRB5*01:133 allele.

Authors

Institutions

Publication Details

Journal
HLA
Published
2025-07-01
DOI
https://doi.org/10.1111/tan.70321
Citations
3
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
2.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HLA‐DRB5*01:133, the First HLA‐DRB5 Allele With Arginine at Position 16 in the Peptide‐Binding Domain

Nuria Calzada, Juan López‐Pérez, A. Balas, Amalia Tejeda Velarde et al.
3 citations
HLA
Immunotherapy and Immune Responses
2.39
article

HLA‐DRB5*01:133, the First HLA‐DRB5 Allele With Arginine at Position 16 in the Peptide‐Binding Domain

Nuria Calzada, Juan López‐Pérez, A. Balas, Amalia Tejeda Velarde, Francisco Javier Gil‐Etayo
article en
3 citations

Abstract

A transition in codon 16 in the peptide-binding domain results in the novel HLA-DRB5*01:133 allele.

HLAVol. 106(1)
Complejo Hospitalario de Salamanca (ES), Instituto de Investigación Biomédica de Salamanca (ES), Comunidad de Madrid (ES)
Openalex Percentile: Top 11%
Immunotherapy and Immune Responses
2.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.